Biopharmaceutical Research Companies Are Developing More Than 430 Medicines for Top Chronic Diseases Affecting Older Americans
phrma: 6/16/14 As life expectancy continues to climb— up to more than 81 years for women and 76 years for men—the growing number of Americans age 65 and older will face new challenges from chronic conditions such as arthritis, Alzheimer’s disease, cardiovascular disease and diabetes, which impact their health, productivity and independence. Those diseases not only […]
Collaborative Development of Clinical Trials Education Programs for African-American Community-Based Organizations
Journal of Cancer Education: June 2014 This paper describes the use of a unique “Learning and Feedbackˮ approach to customize cancer clinical trials education programs for Community Bridges, a peer training intervention designed for African-American communities in North Carolina. Generic community education modules were demonstrated with key community leaders who were designated as trainers. Quantitative and […]
The Graying of Clinical Trials
Pharmexec: June 4, 2014 Patients 65 years of age and over are underrepresented in clinical trials, even though in many therapeutic categories they are the primary drug consumers. But, writes, Sydney Rubin, there are few practical or ethical obstacles to including elderly patients in trials that cannot be overcome. Thanks to efforts of groups like […]
FDA launches openFDA to provide easy access to valuable FDA public data
FDA: June 2, 2014 Today, the U.S. Food and Drug Administration launched openFDA, a new initiative designed to make it easier for web developers, researchers, and the public to access large, important public health datasets collected by the agency. In alignment with the recent Presidential Executive Order on Open Data and the Department of Health and […]
European Medicines Agency welcomes publication of the Clinical Trials Regulation
EMA: 28/05/2014 The European Medicines Agency (EMA) welcomes the publication of the Clinical Trials Regulation in the Official Journal of the European Union (EU). This legislation will open up a new era for the conduct of clinical trials in the EU, ensuring that Europe remains an attractive centre for clinical research. This will foster European competitiveness and […]
Racial diversity crucial to trials of drugs, treatments
Sfgate: Tuesday, May 20, 2014 As a nurse practitioner, Phyllis Howardunderstands the value of clinical trials in testing new drugs or treatment protocols. But as an African American woman, she was leery about the idea of being a test subject. “I considered it being experimented on,” said Howard, 56, of her initial reaction to a suggestion by her […]
Hispanic Accrual on Randomized Cancer Clinical Trials: A Call to Arms
JCO May 19, 2014 The Hispanic population is the fastest growing demographic group in the United States and is expected to triple from 46.7 million to 132.8 million by 2050.1 Hispanics suffer from major health dispar- ities, and they have low participation in cancer screening and preven- tion programs and higher incidence rates for cancers of […]